Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients

African-American patients with end-stage renal disease have historically lower hemoglobin concentrations and higher requirements of erythropoiesis-stimulating agent (ESA). While disparities in health-care access may partially explain these findings, the role of variant hemoglobin, such as sickle tra...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Derebail, Vimal K., Nachman, Patrick H., Key, Nigel S., Ansede, Heather, Falk, Ronald J., Rosamond, Wayne D., Kshirsagar, Abhijit V.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3311876/
https://ncbi.nlm.nih.gov/pubmed/21849972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2011.247
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky